DBT and Lifestyle Change to Prevent Type 2 Diabetes in Adolescents

Sponsor
University of Manitoba (Other)
Overall Status
Recruiting
CT.gov ID
NCT05338944
Collaborator
Diabetes Canada (Other)
15
1
3
29
0.5

Study Details

Study Description

Brief Summary

This research is being conducted to evaluate emotion-focused therapy that incorporates elements of mindfulness, distress tolerance, and relationship support. The investigators want to learn if this therapy, called Dialectical Behavioral Therapy (DBT) will help improve quality of life and weight management in youth at risk for type 2 diabetes. Individuals will be randomly assigned to weekly group based session in one of 3 intervention arms; lifestyle + DBT, lifestyle alone, or a control arm.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Dialectical behavioral therapy
  • Behavioral: Lifestyle
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
15 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
15 youth will be randomized (2:2:1) into one of the three arms of the trial; DBT + lifestyle, lifestyle alone, control15 youth will be randomized (2:2:1) into one of the three arms of the trial; DBT + lifestyle, lifestyle alone, control
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Dialectical Behavioral Therapy (DBT) and Lifestyle Change to Prevent Type 2 Diabetes in Adolescents
Anticipated Study Start Date :
Sep 1, 2022
Anticipated Primary Completion Date :
Jan 31, 2023
Anticipated Study Completion Date :
Jan 31, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: DBT + lifestyle

Participants will receive 90 minutes of dialectical behavioral therapy and 60 minutes of lifestyle sessions each week for 16 weeks.

Behavioral: Dialectical behavioral therapy
Working with psychologists through DBT skills training.

Behavioral: Lifestyle
Working with kinesiologist and registered dietician to improve lifestyle habits.

Experimental: Lifestyle alone

Participants will receive 2 lifestyle sessions per week, one 90 minutes in length and the other 60 minutes for 16 weeks.

Behavioral: Lifestyle
Working with kinesiologist and registered dietician to improve lifestyle habits.

No Intervention: Control

Participants will be included in baseline, endpoint and follow up measurements, but will receive no form of intervention.

Outcome Measures

Primary Outcome Measures

  1. Enrollment rates [6 weeks]

    defined as the number of adolescents/families who consent to participate and are randomized to one of the arms of the study

  2. Adherence to the intervention [16 weeks]

    defined as the percentage of prescribed sessions that adolescents/families attend during the trial

  3. Retention for follow up measurements [one week at week 16 and week 32]

    defined as the number of adolescents who complete follow up measurements at 16 weeks and 32 weeks

Secondary Outcome Measures

  1. Barriers for lifestyle change [2 weeks at 16 weeks]

    What are the barriers for lifestyle change for adolescents. Collected through focus groups and photovoice participation at 16 weeks.

  2. Delivery of behavioral intervention [2 weeks at 16 weeks]

    What are the preferred intervention attributes for delivering a behavioral intervention? Collected from focus groups and feedback forms.

  3. DBT skills training [2 weeks at 16 weeks]

    How appropriate is DBT skills training for adolescents and their families? Collected from focus groups and feedback forms.

  4. DBT benefits and challenges [2 weeks at 16 weeks]

    What are the perceived benefits and challenges associated with DBT-enhanced intensive lifestyle therapy? Collected from focus groups and feedback forms.

  5. Patient centered [2 weeks at 16 weeks]

    How patient-centered are the proposed tools for assessing mental health co-morbidities and self-regulation? Collected from focus groups and feedback forms.

  6. Feedback [2 weeks at 16 weeks]

    What other outcomes should we consider measuring? Collected from focus groups and feedback forms.

Eligibility Criteria

Criteria

Ages Eligible for Study:
14 Years to 17 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • 14-17 years old

  • BMI z-score >1.6

  • signs of mild-moderate depression (PHQ-9 score 5-19)

  • willing and able to comply with study procedures

Exclusion Criteria:
  • more than one health co-morbidity

  • being treated with medication for obesity

  • taking steroids

  • currently being treated for atypical antipsychotics

  • have an orthopedic injury or chronic illness that would prevent them from performing the intervention

  • experienced weight loss or enrolled in weight loss program in the six months prior to the study

  • self reported history of alcoholism or drug abuse

  • history of self-harm or suicide attempts in the past 12 months

  • currently enrolled in psychotherapy or DBT

  • parents do not approve of you participating

  • unable/unwilling to give assent/consent

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Manitoba Winnipeg Manitoba Canada R3E3P4

Sponsors and Collaborators

  • University of Manitoba
  • Diabetes Canada

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Manitoba
ClinicalTrials.gov Identifier:
NCT05338944
Other Study ID Numbers:
  • HS24295
First Posted:
Apr 21, 2022
Last Update Posted:
Jul 19, 2022
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 19, 2022